Pre-treatment protoporphyrin IX concentration in actinic keratosis lesions may be a predictive biomarker of response to aminolevulinic-acid based photodynamic therapy

BACKGROUND: Although Aminolevulinic Acid (ALA)-induced protoporphyrin IX (PpIX) photodynamic therapy (PDT) is an effective FDA-approved therapy for actinic keratosis (AK), a substantial fraction of patients (up to 25%) do not respond to treatment. This study examined the feasibility of using pre-tre...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Photodiagnosis Photodyn Ther
Main Authors: Kanick, SC, Davis, SC, Zhao, Y, Sheehan, KL, Hasan, T, Maytin, EV, Pogue, BW, Chapman, MS
Format: Artigo
Jezik:Inglês
Izdano: 2015
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4684466/
https://ncbi.nlm.nih.gov/pubmed/26480810
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pdpdt.2015.10.006
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki